Client News
AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin
17th July 2023
Rentschler Biopharma: Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim
12th July 2023
Carbios announces the success of its capital increase with preferential subscription rights of approximately 141 million euros, the largest on Euronext Growth since 2015
11th July 2023
Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
11th July 2023
Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation
11th July 2023
Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
6th July 2023
AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
6th July 2023
Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
6th July 2023
There is no more content to load